Find clinical trials for Ovarian Cancer in Salt Lake City, UT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Salt Lake City, UT, USA:
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Salt Lake City, Utah, United States and 213 other locations
to the enrollment of patients diagnosed with triple-negative breast cancer or ovarian cancer. Dose expansion will only be ...
Phase 1
Salt Lake City, Utah, United States and 1 other location
To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer...
Phase 3
Ogden, Utah, United States of America and 119 other locations
Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...
Phase 3
Ogden, Utah, United States and 189 other locations
ecteribulin (MORAb-202) and compare it to Investigator's choice (IC) chemotherapy in female participants with platinum-resistant HGS ovarian....
Phase 2
Salt Lake City, Utah, United States and 82 other locations
This study aims to assess efficacy of Niraparib (GSK3985771) as maintenance treatment in participants with Stage III or IV ovarian cancer...
Phase 3
Salt Lake City, Utah, United States and 194 other locations
in participants with solid tumors.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be remov...
Phase 1, Phase 2
West Valley City, Utah, United States of America and 21 other locations
following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...
Phase 3
Salt Lake City, Utah, United States and 237 other locations
preliminary antitumor activity of NKT3447 in adult subjects with cyclin E1 (CCNE1) amplified ovarian cancer at the RDEs selected i...
Phase 1
West Valley City, Utah, United States of America and 4 other locations
ultralow dose gemcitabine in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma ba...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 67 other locations
Clinical trials
Research sites
Resources
Legal